Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+4.6%
5Y CAGR+11.9%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
+4.6%/yr
vs +21.8%/yr prior
5Y CAGR
+11.9%/yr
Recent deceleration
Acceleration
-17.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $220.89M | +16.4% |
| 2024 | $189.74M | +58.9% |
| 2023 | $119.37M | -38.2% |
| 2022 | $193.21M | +40.3% |
| 2021 | $137.69M | +9.2% |
| 2020 | $126.06M | +118.4% |
| 2019 | $-686.79M | -882.9% |
| 2018 | $87.73M | +20.1% |
| 2017 | $73.03M | +14.0% |
| 2016 | $64.06M | - |